Heart Valve Devices | Market Insights | Europe | 2022
The European heart valve device market has been negatively impacted by the global COVID-19 pandemic; however, in the longer term, the market will be driven by an aging population in this country, improving access to treatment, positive results from THV device clinical trials, new product launches, and the rapid adoption of THV devices, resulting in moderate growth through 2030.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for heart valve devices in Europe across an 11-year period.